A detailed history of Members Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Members Trust CO holds 7,339 shares of ABBV stock, worth $1.49 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
7,339
Previous 8,352 12.13%
Holding current value
$1.49 Million
Previous $1.43 Million 1.19%
% of portfolio
0.05%
Previous 0.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $165,969 - $201,921
-1,013 Reduced 12.13%
7,339 $1.45 Million
Q2 2024

Jul 29, 2024

BUY
$154.79 - $180.76 $701,663 - $819,385
4,533 Added 118.7%
8,352 $1.43 Million
Q1 2024

Apr 25, 2024

BUY
$159.82 - $182.1 $93,494 - $106,528
585 Added 18.09%
3,819 $695,000
Q4 2023

Jan 30, 2024

SELL
$137.6 - $154.97 $55,040 - $61,988
-400 Reduced 11.01%
3,234 $501,000
Q3 2023

Oct 06, 2023

SELL
$133.59 - $154.65 $23,511 - $27,218
-176 Reduced 4.62%
3,634 $541,000
Q2 2023

Jul 18, 2023

BUY
$132.51 - $164.9 $504,863 - $628,269
3,810 New
3,810 $513,000
Q3 2022

Nov 07, 2022

BUY
$134.21 - $153.93 $75,828 - $86,970
565 Added 12.96%
4,924 $661,000
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $18,716 - $23,794
136 Added 3.22%
4,359 $668,000
Q1 2022

Aug 03, 2022

SELL
$131.98 - $163.75 $138,579 - $171,937
-1,050 Reduced 19.91%
4,223 $685,000
Q4 2021

Jan 24, 2022

BUY
$107.43 - $135.93 $57,045 - $72,178
531 Added 11.2%
5,273 $714,000
Q3 2021

Nov 10, 2021

SELL
$106.4 - $120.78 $504,548 - $572,738
-4,742 Reduced 50.0%
4,742 $516,000
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $547,108 - $621,050
5,142 Added 118.42%
9,484 $1.02 Million
Q2 2021

Aug 06, 2021

SELL
$105.21 - $117.21 $32,089 - $35,749
-305 Reduced 6.56%
4,342 $489,000
Q1 2021

May 26, 2021

SELL
$102.3 - $112.62 $46,444 - $51,129
-454 Reduced 8.9%
4,647 $503,000
Q4 2020

Jan 25, 2021

BUY
$80.49 - $108.67 $9,658 - $13,040
120 Added 2.41%
5,101 $547,000
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $7,989 - $9,377
-93 Reduced 1.83%
4,981 $436,000
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $141,604 - $189,487
-1,930 Reduced 27.56%
5,074 $498,000
Q1 2018

May 22, 2018

BUY
$92.01 - $123.21 $147,676 - $197,752
1,605 Added 29.73%
7,004 $663,000
Q4 2017

Feb 15, 2018

BUY
$89.56 - $98.21 $70,304 - $77,094
785 Added 17.01%
5,399 $522,000
Q3 2017

Oct 18, 2017

BUY
$69.85 - $89.22 $12,014 - $15,345
172 Added 3.87%
4,614 $410,000
Q2 2017

Aug 07, 2017

BUY
N/A
4,442
4,442 $322,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Members Trust CO Portfolio

Follow Members Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Members Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Members Trust CO with notifications on news.